NCT02185560 2026-03-02
JPMS-DTC
Bayer
Active not recruiting
Clinical Trials
22 trialsNCT02184416 2026-02-27
ADONIS
Pfizer
Completed
NCT05594147 2023-11-07
ROCURS
Bayer
Completed
NCT02303444 2023-06-08
RIFTOS MKI
Bayer
Completed
NCT03644511 2020-08-21
SORAGO-HCC
Bayer
Terminated
NCT01195649 2019-06-04
Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based Therapy
Bayer
Terminated
NCT01933945 2018-11-06
OPTIMIS
Bayer
Completed
NCT01411423 2018-06-06
Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan
Bayer
Completed
NCT01412671 2018-06-06
Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program
Bayer
Completed
NCT01982097 2018-02-07
SANE
Bayer
Completed
NCT01839630 2017-12-20
SUCCESS
Bayer
Completed
NCT01728948 2017-11-09
Sorafenib in Elderly mRCC
Bayer
Completed
NCT01751763 2017-09-25
SECURE
Bayer
Completed
NCT01539681 2016-02-18
STELLA
Bayer
Completed
NCT01908322 2015-11-11
SORINT
Bayer
Completed
NCT01012011 2015-09-21
Regulatory Post Marketing Surveillance Study on Nexavar®
Bayer
Completed
NCT01353794 2015-01-30
POWER-NEXT
Bayer
Withdrawn
NCT01508364 2015-01-21
NEXTAR
Bayer
Completed
NCT00792350 2014-05-14
INSIGHT
Bayer
Completed
NCT01449825 2014-04-21
Hepatic Monitoring for Pazopanib
GlaxoSmithKline
Completed
NCT00771147 2012-06-15
PONDIAC
Bayer
Completed
NCT00895674 2010-09-30
Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar
Bayer
Completed